Cardiology
From the Journals
AHA scientific statement on rapid evaluation for suspected TIA
A key aim of the statement is to help clinicians properly risk-stratify patients with suspected TIA.
Commentary
Damar Hamlin’s cardiac arrest: Key lessons
The goal of this discussion is to describe a systematic approach to evaluation and management of an athlete suffering blunt force chest and neck...
Feature
Will your smartphone be the next doctor’s office?
A fingertip pressed against a phone’s camera lens can measure a heart rate.
From the Journals
Brain differences suggest therapeutic targets in Takotsubo
A new study has identified differences in the brain between patients with Takotsubo syndrome, a cardiomyopathy triggered by intense emotional...
From the Journals
Simulation-based training effective for transesophageal echo
Cardiology fellows who learned transesophageal echocardiography using simulations scored higher on both theoretical and practical tests than those...
News
Possible bivalent vaccine link to strokes in people over 65
The CDC and FDA do not recommend people change their vaccine practices.
Conference Coverage
Atrial failure or insufficiency: A new syndrome
The syndrome may explain heart failure in patients with preserved pump function, according to researchers.
Commentary
What is the optimal pad position in transcutaneous pacing?
Transvenous pacing is typically the most effective therapy for unstable bradycardia but it is invasive, takes some time to perform.
Commentary
A remote mountain bike crash forces a doctor to take knife in hand
An emergency medicine doctor stops mountain biking to help a man lying on a trail, not moving but occasionally breathing.
From the Journals
LDL cholesterol triglycerides ‘robust’ ASCVD risk marker
A large dual-method Danish population study identified high LDL triglyceride levels as a risk marker for atherosclerotic cardiovascular disease....
Feature
Recount of FOURIER data finds higher mortality with evolocumab; trialists push back
A readjudication of mortality data from the FOURIER trial by outside researchers concludes CV death was higher with evolocumab than originally...